Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01868347
Other study ID # CEI-20686
Secondary ID
Status Recruiting
Phase Phase 3
First received May 23, 2013
Last updated June 5, 2013
Start date February 2013
Est. completion date December 2014

Study information

Verified date May 2013
Source University of Turin, Italy
Contact n/a
Is FDA regulated No
Health authority Italy: National Institute of Health
Study type Interventional

Clinical Trial Summary

Analysis of the specific elastance during general anesthesia in patients treated with RARP (robotic assisted radical prostatectomy), to evaluate the efficacy of the preemptive strategy, involving recruitment maneuver and setting of 10 cmH2O PEEP before induction of pneumoperitoneum and trendelenburg position.


Description:

RARP (robotic assisted radical prostatectomy) requires the induction of pneumoperitoneum and the trendelenburg position, causing increase in the intra-abdominal pressure and cephalic shift of the diaphragm, with consequent airway closure and collapse of the dependent regions of the lung.

Obese subjects present an increased risk of respiratory complications, caused not only by the surgical procedure itself, but also by the respiratory mechanics changes associated with the body mass. In obese patients we can observe higher values of lung and chest wall elastance, with reduction in ventilation-perfusion ratio.

The partitioning between lung and chest wall elastance can improve ventilatory setting and mechanics parameters of ventilation.

In every patient we will place, after anesthesia induction, a catheter to get esophageal and gastric pressure that represent pleural and abdominal pressure.

Ventilation will be conducted with a tidal volume of 8-10 ml/kg (IBW) and a respiratory rate adequate to maintain a physiological level of Pa CO2.

The preemptive strategy involves recruitment maneuver and setting of 10 cmH2O PEEP before induction of pneumoperitoneum and trendelenburg position in the treatment group, while the current procedure provides it afterwards (control group).


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- BMI >= 30

- Robotic-assisted laparoscopic prostatectomy

Exclusion Criteria:

- Chronic cardiac or pulmonary diseases

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
treatment
preemptive PEEP before pneumoperitoneum and trendelenburg
control
PEEP after pneumoperitoneum and trendelenburg

Locations

Country Name City State
Italy A.O.U San Luigi Gonzaga Hospital, Univesity of Turin Turin

Sponsors (1)

Lead Sponsor Collaborator
University of Turin, Italy

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Other variation of gas exchange in post operative period at 1 week (average duration) Yes
Primary evaluation of arterial oxygenation at 6 hours (average duration of surgery procedure) No
Secondary evaluation of specific static elastance of the lung Evaluation of the elastic properties of the lung (specific static elastance) at 6 hours (average duration of surgery procedure) No
Secondary evaluation of difference between arterial end-tidal partial pressure of carbon dioxide difference between arterial end-tidal partial pressure of carbon dioxide is an indicator of lung collapse and reopening after open-lung PEEP, which in turn reduce dead space at 6 hours (average duration of surgery procedure) No